BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37273877)

  • 21. Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: The pooling project.
    Schaefer EJ; Ikezaki H; Diffenderfer MR; Lim E; Liu CT; Hoogeveen RC; Guan W; Tsai MY; Ballantyne CM
    Atherosclerosis; 2023 Feb; 367():15-23. PubMed ID: 36724690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of 10-year cumulative blood pressure exposure on atherosclerotic cardiovascular disease of different age groups: kailuan cohort study.
    Guo L; Tian F; Wang J; Xu W; Li W; Hou X; Zheng M; Yang X; Gao L; Chen S; Zhang N; Wu S
    Front Cardiovasc Med; 2024; 11():1341097. PubMed ID: 38361586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol.
    Al-Sabti H; Al-Hinai AT; Al-Zakwani I; Al-Hashmi K; Al Mahmeed W; Arafah M; Shehab A; Al Tamimi O; Al Awadhi M; Al Herz S; Al Anazi F; Al Nemer K; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Baslaib FOAS; Amin H; Al-Waili K; Al-Rasadi K
    Oman Med J; 2022 Mar; 37(2):e367. PubMed ID: 35449790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood.
    Shoar S; Ikram W; Shah AA; Farooq N; Gouni S; Khavandi S; Tabibzadeh E; Khavandi S
    Rev Cardiovasc Med; 2021 Jun; 22(2):295-299. PubMed ID: 34258898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
    Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between essential trace element mixture and atherosclerotic cardiovascular disease risk among Chinese community-dwelling older adults.
    Meng XL; Wang Y; Wang HL; Nie HH; Cheng BJ; Cao HJ; Li XD; Wang SF; Chen GM; Tao FB; Sheng J; Yang LS
    Environ Sci Pollut Res Int; 2022 Dec; 29(60):90351-90363. PubMed ID: 35869340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Association between high-density lipoprotein cholesterol level and cardiovascular disease and all-cause mortality in the elderly population].
    Yu JX; Wu SL; Chen SH; Liu Y; Feng MK; Yang Y; Li SJ; Liu XK; Yang N; Li YM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Aug; 50(8):791-798. PubMed ID: 35982012
    [No Abstract]   [Full Text] [Related]  

  • 29. Current trends in non-HDL cholesterol and LDL cholesterol levels in adults with atherosclerotic cardiovascular disease.
    Vega GL; Grundy SM
    J Clin Lipidol; 2019; 13(4):563-567. PubMed ID: 31248654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Association Between Low-Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts.
    Nanna MG; Navar AM; Wojdyla D; Peterson ED
    J Am Geriatr Soc; 2019 Dec; 67(12):2560-2567. PubMed ID: 31411740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-high-density lipoprotein cholesterol and mortality among peritoneal dialysis patients.
    Yu J; Xia X; Lin T; Huang N; Qiu Y; Yang X; Mao H; Chen W; Huang F
    J Clin Lipidol; 2021; 15(5):732-742. PubMed ID: 34312083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individual and combined contributions of non-high-density lipoprotein cholesterol and brachial-ankle pulse wave velocity to cardiovascular disease risk: Results of a prospective study using the Kailuan cohort.
    Zheng Q; Wang H; Wang X; Lan Y; Wu W; Yu X; Huang Z; Chen Z; Cai Z; Lin Q; Zhou H; Zhu Y; Liu M; Wu K; Zheng H; Wu S; Chen Y
    Front Cardiovasc Med; 2023; 10():1105464. PubMed ID: 36844718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglyceride levels in the Arabian Gulf.
    Al-Hashmi K; Al-Zakwani I; Al Mahmeed W; Arafah M; Al-Hinai AT; Shehab A; Al Tamimi O; Al Awadhi M; Al Herz S; Al Anazi F; Al Nemer K; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Baslaib FO; Amin H; Santos RD; Al-Waili K; Al-Rasadi K
    J Clin Lipidol; 2016; 10(2):368-77. PubMed ID: 27055968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
    Mora S; Buring JE; Ridker PM; Cui Y
    Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
    Ference BA; Ginsberg HN; Graham I; Ray KK; Packard CJ; Bruckert E; Hegele RA; Krauss RM; Raal FJ; Schunkert H; Watts GF; Borén J; Fazio S; Horton JD; Masana L; Nicholls SJ; Nordestgaard BG; van de Sluis B; Taskinen MR; Tokgözoglu L; Landmesser U; Laufs U; Wiklund O; Stock JK; Chapman MJ; Catapano AL
    Eur Heart J; 2017 Aug; 38(32):2459-2472. PubMed ID: 28444290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atherosclerotic cardiovascular disease in hyperalphalipoproteinemia due to LIPG variants.
    Cole J; Blackhurst DM; Solomon GAE; Ratanjee BD; Benjamin R; Marais AD
    J Clin Lipidol; 2021; 15(1):142-150.e2. PubMed ID: 33414088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Triglyceride to high-density lipoprotein cholesterol ratio and incident of diabetes mellitus: a secondary retrospective analysis based on a Chinese cohort study.
    Chen Z; Hu H; Chen M; Luo X; Yao W; Liang Q; Yang F; Wang X
    Lipids Health Dis; 2020 Mar; 19(1):33. PubMed ID: 32131838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Atherosclerotic Cardiovascular Disease Risk in Patients With Cancer: A Population-Based Study.
    Yang L; Zhang N; Yue Q; Song W; Zheng Y; Huang S; Qiu J; Tse G; Li G; Wu S; Liu T
    Curr Probl Cardiol; 2023 Jul; 48(7):101693. PubMed ID: 36924906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Non-Linear Association of High-Density Lipoprotein Cholesterol with All-Cause and Cause-Specific Mortality in Diabetic Patients.
    Yan YQ; Chen J; Huang YQ
    Diabetes Metab Syndr Obes; 2021; 14():2851-2862. PubMed ID: 34188508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.